SANA Competitors & Alternatives
Compare Sana Biotechnology Inc with similar stocks in the same industry
Biotechnology
SANA
Main Stock$1.90
-5.94%
Tradestie Score
47
Market Cap
$951.83M
Analyst Upside
+343.6%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 3/10
Drug Discovery Biotech
Cell Therapy
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
+0.04%
|
$683.46M | - | 49 | Compare |
|
ANL
ANL
|
$9.87
-6.97%
|
$677.47M | - | 48 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$8.83
-3.87%
|
$665.30M | 10.1 | 46 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$15.16
-3.22%
|
$626.91M | - | 35 | Compare |
|
SVRA
Savara Inc.
|
$4.45
-4.20%
|
$611.84M | - | 56 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
+0.04%
|
$608.81M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$7.90
-3.48%
|
$541.60M | - | 54 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.64
-0.05%
|
$540.97M | - | 34 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.22
+1.49%
|
$529.35M | 9.7 | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.75
-2.51%
|
$512.39M | - | 37 | Compare |
More SANA Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry